var data={"title":"Epidemiology, pathogenesis, and clinical manifestations of schistosomiasis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Epidemiology, pathogenesis, and clinical manifestations of schistosomiasis</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/contributors\" class=\"contributor contributor_credentials\">Joannes Clerinx, MD, DTM</a></dd><dd><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/contributors\" class=\"contributor contributor_credentials\">Patrick Soentjens, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/contributors\" class=\"contributor contributor_credentials\">Peter F Weller, MD, MACP</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/contributors\" class=\"contributor contributor_credentials\">Elinor L Baron, MD, DTMH</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 22, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H6283708\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Schistosomiasis is a disease caused by infection with parasitic blood flukes. It is also known as &quot;bilharziasis&quot; after Theodor Bilharz, who first identified the parasite in 1852.</p><p>The parasites that cause schistosomiasis live in certain types of freshwater snails. Emergence of cercariae (the infectious form of the parasite) from the snail leads to contamination of the water. Individuals can become infected when skin comes in contact with contaminated water and is penetrated by cercariae.</p><p>The epidemiology, pathogenesis, and clinical features of schistosomiasis will be reviewed here. The diagnosis, treatment, and prevention of schistosomiasis are discussed separately. (See <a href=\"topic.htm?path=diagnosis-of-schistosomiasis\" class=\"medical medical_review\">&quot;Diagnosis of schistosomiasis&quot;</a> and <a href=\"topic.htm?path=treatment-and-prevention-of-schistosomiasis\" class=\"medical medical_review\">&quot;Treatment and prevention of schistosomiasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H6283714\"><span class=\"h1\">MICROBIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Five schistosome species can cause infection in humans. The three major species are <em>Schistosoma mansoni </em>(Africa and South America), <em>S. japonicum</em> (East Asia), and <em>S. haematobium</em> (Africa and Middle East). In general, <em>S. mansoni </em>and <em>S. japonicum</em> cause intestinal tract disease, while <em>S. haematobium</em> causes genitourinary tract disease. The two minor species are <em>S. mekongi</em> (Laos, Cambodia) and <em>S. intercalatum</em> (West and Central Africa); both are tropic for the intestines and liver. <em>S. mansoni</em> infection occurs primarily among humans (as well as some primates). <em>S. japonicum</em>, <em>S. mekongi</em>, and <em>S. intercalatum</em> are primarily zoonotic species with a broad spectrum of mammalian hosts [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/1\" class=\"abstract_t\">1</a>]. Mixed infection has been observed among humans in some regions, predominantly with <em>S. mansoni</em> and <em>S. haematobium </em>[<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/2,3\" class=\"abstract_t\">2,3</a>].</p><p>Hybridization among phylogenetically related mammalian schistosome species occurs occasionally in areas where the distinctive snail hosts coexist, and it may expand endemicity. As an example, hybrid species of <em>S. haematobium</em> with <em>S. bovis </em>and<em> S. curassoni</em> (related schistosome species with intestinal tropism infecting cattle) have been identified among humans in northern Senegal [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/4,5\" class=\"abstract_t\">4,5</a>], and hybrid infection of <em>S. haematobium</em> with <em>S. bovis</em> has been described in Mali [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/6\" class=\"abstract_t\">6</a>].</p><p class=\"headingAnchor\" id=\"H6283720\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The prevalence of schistosomiasis is highest in sub-Saharan Africa. Worldwide, it has been estimated that more than 200 million people are infected [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/7,8\" class=\"abstract_t\">7,8</a>], and schistosomiasis may cause up to 200,000 deaths annually [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/9,10\" class=\"abstract_t\">9,10</a>].</p><p>The <a href=\"https://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/schistosomiasis&amp;token=6iyk6bitLYmqw2v0hyEoxDMPnvsPGPTa82QZnbS5DYyTPb+7prZlbGN5LBxSu284wW6FfGbfWq0N3Psj8b61V555DBG2D2vYceMh3sRzeNk3x+Nl+fb5oN/HBFU1bpxL&amp;TOPIC_ID=5717\" target=\"_blank\" class=\"external\">geography</a> of schistosomiasis is as follows [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/11-14\" class=\"abstract_t\">11-14</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>S. mansoni</em> occurs in most of sub-Saharan Africa, the western part of South America (mainly Brazil), and some of the South Caribbean islands.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>S. haematobium</em> infection occurs in foci throughout sub-Saharan Africa, the Middle East along the Tigris and Euphrates, and southern parts of the Arabian Peninsula. In addition, an outbreak due to a <em>S. haematobium</em> complex species occurred among bathers in the Cavu River in Corsica, France [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/13\" class=\"abstract_t\">13</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>S. japonicum</em> occurs along the Yangtze River Basin in China, the southern and eastern islands of the Philippines, and in central Sulawesi, Indonesia.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>S. intercalatum</em> occurs in limited foci in the Congo, Gabon, and Cameroon in Central Africa.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>S. mekongi</em> occurs in the Mekong River Basin (and tributaries) in Laos and Cambodia.</p><p/><p>Infection tends to occur in rural areas; urban areas usually lack the freshwater conditions needed for the snail intermediate host to thrive [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/15\" class=\"abstract_t\">15</a>]. Wet rice culture is an important source of exposure in East Asia and parts of Africa. In Africa, schistosomiasis does not generally occur at altitudes &gt;1800 m because a minimum water temperature is required to complete the parasite cycle in the snail intermediate host. An outbreak of acute infection was reported after a brief exposure to a high-altitude (1630 m) crater lake in Uganda [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/16\" class=\"abstract_t\">16</a>].</p><p>Children acquire the infection by bathing in freshwater ponds, lakes, and rivers contaminated with cercarial larvae. Among children in endemic areas, worm burden increases gradually and culminates during adolescence [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/17,18\" class=\"abstract_t\">17,18</a>]. Most individuals have a mild to moderate parasite load with limited morbidity [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/19,20\" class=\"abstract_t\">19,20</a>]; heavy infection with significant consequence for disease occurs among relatively few individuals in a population [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/21\" class=\"abstract_t\">21</a>].</p><p>Infection can be acquired by travelers following a single exposure. There have been numerous outbreaks of acute schistosomiasis in association with tourism [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/22-24\" class=\"abstract_t\">22-24</a>].</p><p>Infection is not uniformly distributed within communities; this may be attributable to differences in exposure patterns, age-related and acquired resistance, and distribution of infected mollusks [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/21\" class=\"abstract_t\">21</a>].</p><p>Each human schistosome species requires a specific snail (mollusk) species:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>S. mansoni</em> &ndash; <em>Biomphalaria</em> spp</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>S. haematobium</em> and <em>S. intercalatum</em> &ndash; <em>Bulinus</em> spp</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>S. japonicum</em> &ndash; <em>Oncomelania</em> spp</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><em>S. mekongi</em> &ndash; <em>Tricula</em> spp</p><p/><p>These snail species require specific environmental conditions and rarely coexist. The distribution of snail species largely defines the local endemicity of the individual schistosome species.</p><p class=\"headingAnchor\" id=\"H6283726\"><span class=\"h2\">Life cycle</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The life cycle of schistosomiasis is complex and requires both intermediate and definitive hosts (<a href=\"image.htm?imageKey=ID%2F90007\" class=\"graphic graphic_figure graphicRef90007 \">figure 1</a>).</p><p>Human contact with fresh water is required for transmission of schistosomiasis. The life cycle begins with seeding of eggs into fresh water through feces (<em>S. mansoni</em> and <em>S. japonicum</em>) or urine (<em>S. haematobium</em>) from infected humans or animal reservoirs. The eggs hatch and release miracidia, which are viable for up to seven days until they penetrate snail intermediate hosts. The stages in the snail include two generations of sporocysts followed by production of cercariae, which are released from the snail into the water after four to six weeks. Cercariae can survive up to two days in water but are most infectious to humans during the first few hours after release from the snail [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/17\" class=\"abstract_t\">17</a>]. Cercariae penetrate human skin, shed their tails, and become schistosomulae, which migrate through the circulation until they reach the liver where they mature into adults over two to four weeks.</p><p>The adult worms migrate against portal blood flow to the mesenteric venules of the small and large intestine (<em>S. japonicum</em> and <em>S. mekongi</em>), the mesenteric venules of the colon (<em>S. mansoni</em>, <em>S. intercalatum</em>), or the vesical venous plexus (<em>S. haematobium</em>). The male schistosome forms a groove in which the female resides. After one to three months, the females worms (7 to 20 mm) deposit eggs in the small venules of the mesenteric or perivesical systems. The eggs move toward the lumen of the intestine (<em>S. mansoni</em> and <em>S. japonicum</em>) or bladder and ureters (<em>S. haematobium</em>) and are eliminated in feces or urine, respectively. The adult worms usually survive for 5 to 7 years but can persist for up to 30 years [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/25\" class=\"abstract_t\">25</a>].</p><p class=\"headingAnchor\" id=\"H6283902\"><span class=\"h1\">PATHOGENESIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most infected individuals do not develop symptomatic illness. The natural course of the infection depends on the age of primary exposure, the intensity of ongoing exposure, development of immunity against repeat infection, and genetic susceptibility [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/17,26\" class=\"abstract_t\">17,26</a>]. In general, the intensity of infection rises during the first two decades of life and subsequently declines to very low levels in adults, presumably due to development of acquired immunity [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/27-30\" class=\"abstract_t\">27-30</a>]. Repeated administrations of mass treatment substantially diminishes schistosome-associated disease and accelerates the acquisition of a protective immunity [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/31\" class=\"abstract_t\">31</a>].</p><p>In general, clinical disease is caused by the host immune response to migrating eggs [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/32\" class=\"abstract_t\">32</a>]. Adult worms absorb host proteins and coat themselves with host antigens, allowing prolonged residence in the bloodstream with evasion of immune attack [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/33\" class=\"abstract_t\">33</a>].</p><p>Migration of eggs through tissues can be associated with entrapment, inflammation, and subsequent fibrosis [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/17\" class=\"abstract_t\">17</a>]. Eggs are carried via the splanchnic venous system and may embolize to the liver, lungs, spleen, brain, or spinal cord; less common sites of embolization include the skin and peritoneal surfaces [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/34\" class=\"abstract_t\">34</a>]. The trapped eggs secrete proteins and carbohydrates that induce a host Th-2 immune response, leading to an eosinophilic granulomatous reaction [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/35\" class=\"abstract_t\">35</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the bowel, inflammation can result in ulceration, blood loss, and scarring [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/36,37\" class=\"abstract_t\">36,37</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the liver, periportal fibrosis (known as Symmers' pipestem fibrosis) can lead to portal hypertension and subsequent esophageal varices [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/38,39\" class=\"abstract_t\">38,39</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In the bladder, the eggs provoke granulomatous inflammation, ulcerations, and development of pseudopolyps in the vesical and ureteral walls, which may mimic malignancy. In addition, chronic inflammation due to schistosomiasis has been associated with bladder cancer.</p><p/><p>Eradication of adult worms in the setting of acute or early chronic schistosomiasis usually leads to complete remission of urinary and intestinal lesions [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/40-44\" class=\"abstract_t\">40-44</a>].</p><p class=\"headingAnchor\" id=\"H6283780\"><span class=\"h1\">CLINICAL MANIFESTATIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In general, manifestations of acute schistosomiasis syndrome (Katayama fever) are observed among individuals not living in endemic areas, such as travelers; this is likely because these individuals have not yet developed immunity associated with early exposure [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/45,46\" class=\"abstract_t\">45,46</a>]. Swimmer's itch is observed among travelers as well as individuals in endemic areas. Manifestations of chronic infection are generally observed among individuals with ongoing exposure in endemic regions.</p><p>Most individuals with schistosomiasis infection are asymptomatic and have a low parasite burden [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/19\" class=\"abstract_t\">19</a>].</p><p class=\"headingAnchor\" id=\"H6283786\"><span class=\"h2\">Acute infection</span></p><p class=\"headingAnchor\" id=\"H6283793\"><span class=\"h3\">Swimmer's itch</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Skin penetration by cercariae usually goes unnoticed. Some individuals develop an itchy rash (&quot;swimmer's itch&quot;) after swimming in fresh water; this is a localized dermatitis that can result in a pruritic papular or urticarial rash at the site of larval entry [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/46,47\" class=\"abstract_t\">46,47</a>]. The rash is a hypersensitivity reaction that occurs with repeat exposure (never with initial exposure); it typically develops on the feet or lower legs.</p><p>Individuals can develop swimmer's itch in regions where human schistosome species are endemic <span class=\"nowrap\">and/or</span> in regions where transmission of avian or mammalian (nonhuman) schistosome species occurs.</p><p class=\"headingAnchor\" id=\"H6283799\"><span class=\"h3\">Acute schistosomiasis syndrome</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Acute schistosomiasis syndrome (known as Katayama fever) is a systemic hypersensitivity reaction to schistosome antigens and circulating immune complexes that occurs three to eight weeks after infection [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/48\" class=\"abstract_t\">48</a>]. Acute schistosomiasis occurs at the time of initial infection with <em>S. haematobium</em>, <em>S. mansoni</em>, <em>S. intercalatum, </em>and <em>S. mekongi</em>; it can reappear after subsequent infection with <em>S. japonicum</em>. The onset of clinical manifestations coincides with the beginning of egg production, a period of rapid increase in antigen burden. The syndrome occurs most frequently among nonimmune hosts such as travelers and may be observed in more than half of infected individuals [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/46,49,50\" class=\"abstract_t\">46,49,50</a>]. Activities associated with acute schistosomiasis syndrome include bathing and swimming in fresh water, scuba diving, water skiing, and rafting [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/51\" class=\"abstract_t\">51</a>].</p><p>Clinical manifestations of acute schistosomiasis syndrome include sudden onset of fever, urticaria and angioedema, chills, myalgias, arthralgias, dry cough, diarrhea, abdominal pain, and headache [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/52-56\" class=\"abstract_t\">52-56</a>]. Only one or a few of the above symptoms may be observed, and fever is not an essential component of the illness [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/57\" class=\"abstract_t\">57</a>]. The symptoms are usually relatively mild and resolve spontaneously over a period of a few days to a few weeks. Occasionally persistent manifestations are observed including weight loss, dyspnea, and chronic diarrhea. In rare cases, neurologic symptoms suggestive of encephalitis can occur [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/58\" class=\"abstract_t\">58</a>].</p><p>An elevated eosinophil count <span class=\"nowrap\">(&gt;1000/microL)</span> is almost universally present within a few days after onset of symptoms [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/59\" class=\"abstract_t\">59</a>]. Patients with cough <span class=\"nowrap\">and/or</span> dyspnea may have patchy infiltrates on chest radiograph [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/48,56,60\" class=\"abstract_t\">48,56,60</a>].</p><p>The treatment of acute schistosomiasis syndrome is discussed separately. (See <a href=\"topic.htm?path=treatment-and-prevention-of-schistosomiasis\" class=\"medical medical_review\">&quot;Treatment and prevention of schistosomiasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H6283805\"><span class=\"h2\">Chronic infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Chronic infection related to schistosomiasis is most common among individuals in endemic areas with ongoing exposure. However, chronic infection can also occur in individuals with brief exposure such as travelers [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/51,61,62\" class=\"abstract_t\">51,61,62</a>]. The severity of disease is related to the number of eggs trapped in tissues, their anatomic distribution, the duration and intensity of infection, and the host immune response [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/17,63\" class=\"abstract_t\">17,63</a>].</p><p>Symptoms of chronic infection often begin insidiously [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/20\" class=\"abstract_t\">20</a>]. The nature of clinical manifestations depends on the organ tropism of the infecting species. Major organs with potential involvement include the intestinal tract, liver, spleen, genitourinary tract, lungs, and central nervous system.</p><p>Other clinical manifestations that have been observed in association with schistosomiasis include anemia, malnutrition, growth retardation, and general disability [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/64,65\" class=\"abstract_t\">64,65</a>].</p><p class=\"headingAnchor\" id=\"H6283811\"><span class=\"h3\">Intestinal schistosomiasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Intestinal schistosomiasis is caused by infection due to <em>S. mansoni</em>, <em>S. japonicum</em>, <em>S. intercalatum</em>, <em>S. mekongi,</em> and, occasionally, <em>S. haematobium</em>. The most common symptoms include chronic or intermittent abdominal pain, poor appetite, and diarrhea. In heavy infection, chronic colonic ulceration may lead to intestinal bleeding and iron deficiency anemia [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/66-68\" class=\"abstract_t\">66-68</a>]. Intestinal polyps and dysplasia can arise due to granulomatous inflammation surrounding eggs deposited in the bowel wall (<a href=\"image.htm?imageKey=ID%2F94653\" class=\"graphic graphic_picture graphicRef94653 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/69,70\" class=\"abstract_t\">69,70</a>]. Bowel strictures can also develop. In rare cases, an inflammatory mass can lead to obstruction or acute appendicitis [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/71,72\" class=\"abstract_t\">71,72</a>].</p><p class=\"headingAnchor\" id=\"H6283817\"><span class=\"h3\">Hepatosplenic schistosomiasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hepatosplenic schistosomiasis is caused by infection due to <em>S. mansoni</em>, <em>S. japonicum</em>, <em>S. intercalatum</em>, <em>S. mekongi,</em> and, occasionally, <em>S. haematobium</em>. Hepatosplenic schistosomiasis consists of two phases depending on age and duration of infection.</p><p>Among children and adolescents, the predominant pathological process consists of nonfibrotic granulomatous inflammation around trapped eggs in the presinusoidal periportal spaces of the liver. The left liver lobe is enlarged with a sharp edge, and splenomegaly may extend below the umbilicus and into the pelvis in some cases [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/36,73,74\" class=\"abstract_t\">36,73,74</a>]. There are generally no apparent signs of liver dysfunction. Ultrasonography demonstrates widened periportal spaces, which are more pronounced in heavily infected individuals. At this stage, the changes are largely reversible with treatment [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/75\" class=\"abstract_t\">75</a>].</p><p>Among adults with chronic infection (and perhaps genetic predisposition), the predominant pathological process consists of collagen deposition in the periportal spaces, which causes periportal fibrosis (also known as Symmers' pipestem fibrosis) [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/20,74,76,77\" class=\"abstract_t\">20,74,76,77</a>]. This leads to occlusion of the portal veins, portal hypertension with splenomegaly, portocaval shunting, and gastrointestinal varices. On physical examination, the liver is firm and nodular. Hepatocellular liver function is not impaired.</p><p>Ultrasonography may demonstrate periportal fibrosis around portal vein tributaries in the setting of late <em>S. japonicum</em> and <em>S. mansoni</em> infections [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/78-80\" class=\"abstract_t\">78-80</a>]. Splenomegaly, portal vein dimensions, and the presence of collateral vessels may also be observed. Computed tomography (CT) and magnetic resonance imaging (MRI) demonstrate heterogeneity of hepatic parenchyma, periportal fibrosis, and the presence of venous collateral pathways [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/81\" class=\"abstract_t\">81</a>]. At this stage, the changes are only partially reversible with treatment [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/75\" class=\"abstract_t\">75</a>]. (See <a href=\"topic.htm?path=noncirrhotic-portal-hypertension#H64323358\" class=\"medical medical_review\">&quot;Noncirrhotic portal hypertension&quot;, section on 'Schistosomiasis'</a>.)</p><p class=\"headingAnchor\" id=\"H3348962\"><span class=\"h4\">Pulmonary complications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pulmonary manifestations of schistosomiasis occur most frequently among patients with hepatosplenic disease due to chronic infection with <em>S. mansoni</em>, <em>S. japonicum</em>, or <em>S. haematobium</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/82\" class=\"abstract_t\">82</a>]. Development of presinusoidal portal hypertension can lead to development of portosystemic collateral vessels, allowing a path for embolization of schistosome eggs into the pulmonary circulation. Eggs can lodge in pulmonary arterioles (diameter 50 to 100 micrometer) and produce a granulomatous pulmonary endarteritis, with subsequent development of pulmonary hypertension and cor pulmonale [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/83\" class=\"abstract_t\">83</a>]. Progression of disease may be associated with cardiac enlargement and pulmonary artery dilatation. These manifestations represent end-stage disease and are generally irreversible.</p><p>Dyspnea is the primary clinical manifestation [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/84\" class=\"abstract_t\">84</a>]. Chest radiography demonstrates fine miliary nodules. Echocardiography is useful screening tool for pulmonary hypertension in patients with hepatosplenic schistosomiasis [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/85\" class=\"abstract_t\">85</a>].</p><p>In some cases, initiation of antischistosomal therapy may precipitate embolization of adult worms to the lungs, resulting in coughing, wheezing, and pulmonary infiltrates on chest radiography [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/86\" class=\"abstract_t\">86</a>]. The mechanism may involve an immunologic response to exposed or released antigens from dead worms [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/87\" class=\"abstract_t\">87</a>]. These manifestations are generally self-limited and antischistosomal therapy may be continued.</p><p class=\"headingAnchor\" id=\"H7411545\"><span class=\"h3\">Genitourinary schistosomiasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Genitourinary schistosomiasis is caused by infection due to <em>S. haematobium </em>[<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/88-91\" class=\"abstract_t\">88-91</a>]. It can result in infertility and increased risk for HIV transmission.</p><p>In early infection, eggs are excreted in the urine and patients present with microscopic or macroscopic hematuria <span class=\"nowrap\">and/or</span> pyuria [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/41,92-94\" class=\"abstract_t\">41,92-94</a>]. Blood is usually seen at the end of voiding (&quot;terminal hematuria&quot;), although in severe cases hematuria may be observed for the entire duration of voiding [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/17\" class=\"abstract_t\">17</a>]. Men may present with hemospermia [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/94\" class=\"abstract_t\">94</a>].</p><p>In early chronic infection, the eggs provoke granulomatous inflammation, ulcerations, and development of pseudopolyps in the vesical and ureteral walls, which may be observed on cystoscopy and mimic malignancy (<a href=\"image.htm?imageKey=ID%2F94653\" class=\"graphic graphic_picture graphicRef94653 \">picture 1</a>) [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/41,92,93\" class=\"abstract_t\">41,92,93</a>]. Biopsy of such lesions in the setting of suspected malignancy can lead to unexpected visualization of schistosome eggs [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/95\" class=\"abstract_t\">95</a>]. Ultrasonography findings of the urinary tract generally correlate well with burden of infection [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/96\" class=\"abstract_t\">96</a>]. Urinary tract lesions are largely reversible with treatment prior to onset of fibrosis and calcification [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/97-100\" class=\"abstract_t\">97-100</a>].</p><p>In longstanding infection, dysuria and increased urinary frequency are common symptoms. At this stage, the bladder wall is fibrosed and may calcify, producing a characteristic radiographic image (<a href=\"image.htm?imageKey=ID%2F96779\" class=\"graphic graphic_diagnosticimage graphicRef96779 \">image 1</a>). Intravenous pyelogram (IVP) may demonstrate ureteral stricture(s). Ultrasonography of the kidneys and bladder may demonstrate bladder wall irregularities due to granulomas. Hydronephrosis, bladder polyps, and tumors can also be detected.</p><p>Bladder neck obstruction, hydroureter, and hydronephrosis can ensue, leading to renal failure [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/92,95,101,102\" class=\"abstract_t\">92,95,101,102</a>]. Bacterial superinfection can cause acute pyelonephritis. Longstanding infection may also be associated with development of bladder cancer, particularly in combination with other carcinogenic exposures such as tobacco [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/103\" class=\"abstract_t\">103</a>]. (See <a href=\"topic.htm?path=epidemiology-and-risk-factors-of-urothelial-transitional-cell-carcinoma-of-the-bladder\" class=\"medical medical_review\">&quot;Epidemiology and risk factors of urothelial (transitional cell) carcinoma of the bladder&quot;</a>.)</p><p>Female genital manifestations may include hypertrophic and ulcerative lesions of the vulva, vagina, and cervix [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/100,104,105\" class=\"abstract_t\">100,104,105</a>]. Involvement may also include the ovaries or fallopian tubes, which can lead to infertility. Male genital manifestations may include involvement of the epididymis, testicles, spermatic cord, or prostate. Genital lesions may be partially reversible with treatment.</p><p>Genital schistosomiasis may be an independent risk factor for HIV infection [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/106-108\" class=\"abstract_t\">106-108</a>]. (See <a href=\"#H6283865\" class=\"local\">'HIV infection'</a> below.)</p><p class=\"headingAnchor\" id=\"H3328511\"><span class=\"h3\">Glomerular disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Infection due to any schistosomal species can be associated with immune complex glomerulopathy, leading to proteinuria and the nephrotic syndrome. This is discussed separately. (See <a href=\"topic.htm?path=schistosomiasis-and-glomerular-disease\" class=\"medical medical_review\">&quot;Schistosomiasis and glomerular disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H3347989\"><span class=\"h2\">Neuroschistosomiasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Schistosomiasis can cause serious neurologic complications, even among individuals with a relatively low burden of infection (including travelers) [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/109\" class=\"abstract_t\">109</a>]. Neuroschistosomiasis can involve the spinal cord (causing an acute myelopathy) <span class=\"nowrap\">and/or</span> the brain (<a href=\"image.htm?imageKey=ID%2F96780\" class=\"graphic graphic_diagnosticimage graphicRef96780 \">image 2</a> and <a href=\"image.htm?imageKey=ID%2F96781\" class=\"graphic graphic_diagnosticimage graphicRef96781 \">image 3</a>); myelopathy is more common than cerebral disease [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/95,110-115\" class=\"abstract_t\">95,110-115</a>]. Embolization of adult worms to the spinal cord or cerebral microcirculation with subsequent release of eggs leads to an intense inflammatory granulomatous reaction with local tissue destruction and scarring [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/116\" class=\"abstract_t\">116</a>].</p><p>Schistosomiasis accounts for 1 to 4 percent of spinal cord lesions in sub-Saharan Africa and is probably underestimated in endemic populations [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/114,117\" class=\"abstract_t\">114,117</a>]. Spinal cord involvement consists of a rapidly progressive transverse myelitis. It is usually intramedullary but occasionally includes extramedullary involvement, mainly affecting the conus medullaris and the cauda equina [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/118\" class=\"abstract_t\">118</a>]. Patients may present with lower limb pain, lower motor dysfunction, bladder paralysis, and bowel dysfunction [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/119\" class=\"abstract_t\">119</a>].</p><p>Schistosomiasis of the brain may cause single or multiple intracerebral lesions and presents with a wide variety of symptoms including seizures, motor <span class=\"nowrap\">and/or</span> sensory impairment, or a cerebellar syndrome [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/120\" class=\"abstract_t\">120</a>]. Cerebral involvement may occur more frequently than suspected clinically [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/121\" class=\"abstract_t\">121</a>].</p><p>In rare cases, schistosomiasis can cause a multifocal encephalopathy with features similar to acute vasculitis; this may occur as a result of eosinophil-mediated toxicity [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/58\" class=\"abstract_t\">58</a>]. Cerebral vasculitis associated with schistosomiasis in the absence of eosinophilia has also been described [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/122\" class=\"abstract_t\">122</a>].</p><p>Neuroschistosomiasis is a medical emergency; diagnosis and treatment are discussed separately. (See <a href=\"topic.htm?path=diagnosis-of-schistosomiasis#H30355008\" class=\"medical medical_review\">&quot;Diagnosis of schistosomiasis&quot;, section on 'Neuroschistosomiasis'</a> and <a href=\"topic.htm?path=treatment-and-prevention-of-schistosomiasis#H2484977\" class=\"medical medical_review\">&quot;Treatment and prevention of schistosomiasis&quot;, section on 'Neuroschistosomiasis'</a>.)</p><p class=\"headingAnchor\" id=\"H14470957\"><span class=\"h1\">LABORATORY FINDINGS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Eosinophilia is observed in 30 to 60 percent of patients [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/123-125\" class=\"abstract_t\">123-125</a>]. Eosinophilia is very common among patients with acute schistosomiasis infection syndrome, a hypersensitivity that occurs most frequently among travelers with new infection [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/46,57,126\" class=\"abstract_t\">46,57,126</a>]. The degree of eosinophilia depends on the stage, intensity, and duration of infection [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/127\" class=\"abstract_t\">127</a>].</p><p>Eosinophils may be observed in the cerebrospinal fluid (CSF) among patients with neurologic involvement; one review including 231 patients with spinal cord involvement noted presence of CSF eosinophils in 41 percent of cases [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/119\" class=\"abstract_t\">119</a>].</p><p>Anemia may be observed in patients with blood loss due to chronic intestinal or urinary tract schistosomiasis. A fecal occult blood test may be positive in intestinal schistosomiasis if there is a heavy burden of infection [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/128\" class=\"abstract_t\">128</a>].</p><p>Thrombocytopenia may be observed in patients with portal hypertension due to hepatosplenic schistosomiasis secondary to splenic sequestration in an enlarged spleen.</p><p>Liver enzymes are rarely elevated, even in established hepatic fibrosis due to schistosomiasis.</p><p>Hematuria <span class=\"nowrap\">and/or</span> leukocyturia are common in the setting of <em>S. haematobium</em> infection [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/129-133\" class=\"abstract_t\">129-133</a>].</p><p>Diagnostic laboratory tests for schistosomiasis are discussed further separately. (See <a href=\"topic.htm?path=diagnosis-of-schistosomiasis\" class=\"medical medical_review\">&quot;Diagnosis of schistosomiasis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H6283853\"><span class=\"h1\">ASSOCIATED INFECTIONS</span></p><p class=\"headingAnchor\" id=\"H6283859\"><span class=\"h2\">Bacteremia and bacteriuria</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Egg migration through tissues can cause inflammation of the colon or urinary tract, leading to bacteremia <span class=\"nowrap\">and/or</span> bacteriuria [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/59\" class=\"abstract_t\">59</a>]. Infection with any bacterial organism can occur, including recurrent infection due to <em>Salmonella</em> [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/134\" class=\"abstract_t\">134</a>].</p><p class=\"headingAnchor\" id=\"H6283865\"><span class=\"h2\">HIV infection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Schistosome infections appear to have little to no association with HIV infection [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/135,136\" class=\"abstract_t\">135,136</a>]. Infection due to <em>S. haematobium</em> may be associated with increased risk of HIV transmission since eggs can induce inflammation leading to development of ulcerative lesions in the female reproductive tract [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/137-139\" class=\"abstract_t\">137-139</a>]. In addition, schistosomiasis may interfere with the host immune response, increasing susceptibility to HIV infection [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/106,140\" class=\"abstract_t\">106,140</a>]. Coinfection with HIV and schistosomiasis may facilitate HIV replication and cytokine dysregulation [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/141\" class=\"abstract_t\">141</a>]. It has also been suggested that HIV infection may be associated with increased susceptibility to repeat infection with schistosomes [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/142,143\" class=\"abstract_t\">142,143</a>].</p><p>Symptomatic schistosomiasis has also been described in the setting of immune reconstitution syndrome in a patient receiving antiretroviral therapy [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/144\" class=\"abstract_t\">144</a>].</p><p class=\"headingAnchor\" id=\"H6283871\"><span class=\"h2\">Viral hepatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Individuals with hepatitis B and schistosomiasis caused by <em>S. mansoni</em> or <em>S. japonicum</em> have more severe disease and worse prognosis than those infected with either pathogen alone [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/145\" class=\"abstract_t\">145</a>].</p><p>Individuals with hepatitis C virus (HCV) and schistosomiasis appear to have more severe liver disease than those with HCV monoinfection [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/146,147\" class=\"abstract_t\">146,147</a>]. This may be related to alteration of cellular immune responses to HCV antigens that is modulated by schistosomiasis infection, leading to increased levels of HCV RNA and more rapid progression of liver disease [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/148\" class=\"abstract_t\">148</a>].</p><p class=\"headingAnchor\" id=\"H6283883\"><span class=\"h2\">Malaria</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Malaria and schistosomiasis are co-endemic in many areas. Studies have shown coinfection may increase morbidity in hepatosplenic schistosomiasis and alter the host immune response to schistosome antigens [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/140,149\" class=\"abstract_t\">140,149</a>]. In addition, development of hepatocellular carcinoma may be potentiated in coinfected individuals [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/150\" class=\"abstract_t\">150</a>].</p><p>However, coinfection may be protective in urinary schistosomiasis; one study among children (four to eight years of age) with asymptomatic urinary schistosomiasis noted delayed onset to first clinical malaria infection, fewer malarial episodes, and a lower mean parasite density at initial infection compared with children who did not have <em>S. haematobium</em> infection [<a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/151\" class=\"abstract_t\">151</a>].</p><p class=\"headingAnchor\" id=\"H6283927\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Schistosomiasis is a disease caused by infection with parasitic blood flukes. The three major schistosome species that cause infection in humans are <em>Schistosoma mansoni </em>(Africa and South America), <em>Schistosoma japonicum</em> (East Asia), and <em>Schistosoma haematobium</em> (Africa and the Middle East). (See <a href=\"#H6283714\" class=\"local\">'Microbiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The <a href=\"https://wwwnc.cdc.gov/travel/yellowbook/2016/infectious-diseases-related-to-travel/schistosomiasis&amp;token=6iyk6bitLYmqw2v0hyEoxDMPnvsPGPTa82QZnbS5DYyTPb+7prZlbGN5LBxSu284wW6FfGbfWq0N3Psj8b61V555DBG2D2vYceMh3sRzeNk3x+Nl+fb5oN/HBFU1bpxL&amp;TOPIC_ID=5717\" target=\"_blank\" class=\"external\">prevalence</a> of schistosomiasis is highest in sub-Saharan Africa. Children acquire the infection by bathing in fresh water contaminated with cercariae (the infectious form of the parasite). Worm burden gradually increases to culminate during adolescence. Most individuals have a mild to moderate parasite load with limited morbidity; heavy infection with significant consequence for disease occurs among relatively few individuals in a population. (See <a href=\"#H6283720\" class=\"local\">'Epidemiology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The life cycle of schistosomiasis is complex and requires both intermediate and definitive hosts (<a href=\"image.htm?imageKey=ID%2F90007\" class=\"graphic graphic_figure graphicRef90007 \">figure 1</a>). Cercariae released from snails in fresh water penetrate human skin and migrate to the liver, where they mature into adults. The adult worms migrate to the mesenteric venules of the intestine (<em>S. japonicum</em> and <em>S. mekongi</em>), the colon (<em>S. mansoni</em>), or the vesical venous plexus (<em>S. haematobium</em>). The female worms deposit eggs in the portal or perivesical systems, which migrate to the lumen of the intestine (<em>S. mansoni</em> and <em>S. japonicum</em>) or bladder (<em>S. haematobium</em>) and are excreted via stool or urine, respectively. The eggs hatch and release miracidia, which penetrate snail intermediate hosts; subsequently cercariae are produced. (See <a href=\"#H6283726\" class=\"local\">'Life cycle'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Manifestations of acute infection are generally observed among individuals not living in endemic areas, such as travelers; this is likely because these individuals do not present with hypersensitivity at first exposure. Acute infection can present with &quot;swimmer's itch&quot; <span class=\"nowrap\">and/or</span> acute schistosomiasis syndrome (Katayama fever), a systemic hypersensitivity reaction to schistosome antigens and circulating immune complexes. (See <a href=\"#H6283786\" class=\"local\">'Acute infection'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Manifestations of chronic infection are generally observed among individuals with ongoing exposure in endemic regions. Disease is caused by the host immune response to migrating eggs. In the bowel, inflammation can result in ulceration, blood loss, and scarring. In the liver, periportal fibrosis (Symmers' pipestem fibrosis) can lead to portal hypertension and subsequent esophageal varices. In the bladder, granulomatous inflammation can result in development of pseudopolyps <span class=\"nowrap\">and/or</span> urinary tract obstruction leading to renal failure. (See <a href=\"#H6283805\" class=\"local\">'Chronic infection'</a> above and <a href=\"#H6283902\" class=\"local\">'Pathogenesis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Schistosomiasis can cause serious neurologic complications, even among individuals with a relatively low burden of infection, including travelers. Neuroschistosomiasis can involve the spinal cord (causing an acute myelopathy) <span class=\"nowrap\">and/or</span> the brain. (See <a href=\"#H3347989\" class=\"local\">'Neuroschistosomiasis'</a> above.)</p><p/><p class=\"headingAnchor\" id=\"H6290124\"><span class=\"h1\">ACKNOWLEDGMENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The editorial staff at UpToDate would like to acknowledge Karin Leder, MD, and Peter Weller, MD, who contributed to an earlier version of this topic.</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/1\" class=\"nounderline abstract_t\">Rudge JW, Webster JP, Lu DB, et al. Identifying host species driving transmission of schistosomiasis japonica, a multihost parasite system, in China. Proc Natl Acad Sci U S A 2013; 110:11457.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/2\" class=\"nounderline abstract_t\">Meurs L, Mbow M, Vereecken K, et al. Bladder morbidity and hepatic fibrosis in mixed Schistosoma haematobium and S. mansoni Infections: a population-wide study in Northern Senegal. PLoS Negl Trop Dis 2012; 6:e1829.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/3\" class=\"nounderline abstract_t\">Meurs L, Mbow M, Vereecken K, et al. Epidemiology of mixed Schistosoma mansoni and Schistosoma haematobium infections in northern Senegal. Int J Parasitol 2012; 42:305.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/4\" class=\"nounderline abstract_t\">Huyse T, Webster BL, Geldof S, et al. Bidirectional introgressive hybridization between a cattle and human schistosome species. PLoS Pathog 2009; 5:e1000571.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/5\" class=\"nounderline abstract_t\">Webster BL, Diaw OT, Seye MM, et al. Introgressive hybridization of Schistosoma haematobium group species in Senegal: species barrier break down between ruminant and human schistosomes. PLoS Negl Trop Dis 2013; 7:e2110.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/6\" class=\"nounderline abstract_t\">Soentjens P, Cnops L, Huyse T, et al. Diagnosis and Clinical Management of Schistosoma haematobium-Schistosoma bovis Hybrid Infection in a Cluster of Travelers Returning From Mali. Clin Infect Dis 2016; 63:1626.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/7\" class=\"nounderline abstract_t\">King CH, Dickman K, Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005; 365:1561.</a></li><li class=\"breakAll\">Ultroska JA, Chen MG, Dixon H, et al. An estimate of global needs for praziquantel within schistosomiasis control programmes.  WHO/SCHISTO/89.102. Division of Control of Tropical Diseases, WHO, Gevena, 1989.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/9\" class=\"nounderline abstract_t\">Chitsulo L, Engels D, Montresor A, Savioli L. The global status of schistosomiasis and its control. Acta Trop 2000; 77:41.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/10\" class=\"nounderline abstract_t\">Mathers CD, Ezzati M, Lopez AD. Measuring the burden of neglected tropical diseases: the global burden of disease framework. PLoS Negl Trop Dis 2007; 1:e114.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/11\" class=\"nounderline abstract_t\">Nicolls DJ, Weld LH, Schwartz E, et al. Characteristics of schistosomiasis in travelers reported to the GeoSentinel Surveillance Network 1997-2008. Am J Trop Med Hyg 2008; 79:729.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/12\" class=\"nounderline abstract_t\">Grobusch MP, M&uuml;hlberger N, Jelinek T, et al. Imported schistosomiasis in Europe: sentinel surveillance data from TropNetEurop. J Travel Med 2003; 10:164.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/13\" class=\"nounderline abstract_t\">Berry A, Mon&eacute; H, Iriart X, et al. Schistosomiasis haematobium, Corsica, France. Emerg Infect Dis 2014; 20:1595.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/14\" class=\"nounderline abstract_t\">Holtfreter MC, Mon&eacute; H, M&uuml;ller-St&ouml;ver I, et al. Schistosoma haematobium infections acquired in Corsica, France, August 2013. Euro Surveill 2014; 19.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/15\" class=\"nounderline abstract_t\">Mott KE, Desjeux P, Moncayo A, et al. Parasitic diseases and urban development. Bull World Health Organ 1990; 68:691.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/16\" class=\"nounderline abstract_t\">Lachish T, Tandlich M, Grossman T, Schwartz E. High rate of schistosomiasis in travelers after a brief exposure to the high-altitude Nyinambuga crater lake, Uganda. Clin Infect Dis 2013; 57:1461.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/17\" class=\"nounderline abstract_t\">Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet 2006; 368:1106.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/18\" class=\"nounderline abstract_t\">Gryseels B, Stelma F, Talla I, et al. Immuno-epidemiology of Schistosoma mansoni infections in a recently exposed community in Senegal. Mem Inst Oswaldo Cruz 1995; 90:271.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/19\" class=\"nounderline abstract_t\">Gryseels B, De Vlas SJ. Worm burdens in schistosome infections. Parasitol Today 1996; 12:115.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/20\" class=\"nounderline abstract_t\">Tukahebwa EM, Magnussen P, Madsen H, et al. A very high infection intensity of Schistosoma mansoni in a Ugandan Lake Victoria Fishing Community is required for association with highly prevalent organ related morbidity. PLoS Negl Trop Dis 2013; 7:e2268.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/21\" class=\"nounderline abstract_t\">Clements AC, Moyeed R, Brooker S. Bayesian geostatistical prediction of the intensity of infection with Schistosoma mansoni in East Africa. Parasitology 2006; 133:711.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/22\" class=\"nounderline abstract_t\">Bisharat N, Strahilevitz J, Ephros M, Raz R. Outbreak of acute schistosomiasis among Israeli rafters on the Omo River in Ethiopia. Am J Trop Med Hyg 1998; 59:504.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/23\" class=\"nounderline abstract_t\">Istre GR, Fontaine RE, Tarr J, Hopkins RS. Acute schistosomiasis among Americans rafting the Omo River, Ethiopia. JAMA 1984; 251:508.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/24\" class=\"nounderline abstract_t\">Lambertucci JR, Drummond SC, Voieta I, et al. An outbreak of acute Schistosoma mansoni Schistosomiasis in a nonendemic area of Brazil: a report on 50 cases, including 5 with severe clinical manifestations. Clin Infect Dis 2013; 57:e1.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/25\" class=\"nounderline abstract_t\">Arnon R. Life span of parasite in schistosomiasis patients. Isr J Med Sci 1990; 26:404.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/26\" class=\"nounderline abstract_t\">Abel L, Demenais F, Prata A, et al. Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am J Hum Genet 1991; 48:959.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/27\" class=\"nounderline abstract_t\">Butterworth AE. Immunological aspects of human schistosomiasis. Br Med Bull 1998; 54:357.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/28\" class=\"nounderline abstract_t\">Gryseels B, Stelma FF, Talla I, et al. Epidemiology, immunology and chemotherapy of Schistosoma mansoni infections in a recently exposed community in Senegal. Trop Geogr Med 1994; 46:209.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/29\" class=\"nounderline abstract_t\">Kabatereine NB, Vennervald BJ, Ouma JH, et al. Adult resistance to schistosomiasis mansoni: age-dependence of reinfection remains constant in communities with diverse exposure patterns. Parasitology 1999; 118 ( Pt 1):101.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/30\" class=\"nounderline abstract_t\">Ouma JH, Fulford AJ, Kariuki HC, et al. The development of schistosomiasis mansoni in an immunologically naive immigrant population in Masongaleni, Kenya. Parasitology 1998; 117 ( Pt 2):123.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/31\" class=\"nounderline abstract_t\">Mutapi F, Maizels R, Fenwick A, Woolhouse M. Human schistosomiasis in the post mass drug administration era. Lancet Infect Dis 2017; 17:e42.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/32\" class=\"nounderline abstract_t\">Pearce EJ. Priming of the immune response by schistosome eggs. Parasite Immunol 2005; 27:265.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/33\" class=\"nounderline abstract_t\">Keating JH, Wilson RA, Skelly PJ. No overt cellular inflammation around intravascular schistosomes in vivo. J Parasitol 2006; 92:1365.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/34\" class=\"nounderline abstract_t\">Lambertucci JR, Rayes AA, Barata CH, et al. Acute schistosomiasis: report on five singular cases. Mem Inst Oswaldo Cruz 1997; 92:631.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/35\" class=\"nounderline abstract_t\">Coutinho HM, Acosta LP, Wu HW, et al. Th2 cytokines are associated with persistent hepatic fibrosis in human Schistosoma japonicum infection. J Infect Dis 2007; 195:288.</a></li><li class=\"breakAll\">Lambertucci RL. Schistosoma mansoni: Pathological and Clinical Aspects. In: Human Schistosomiasis, Jordan P, Webbe G, Sturrock FS (Eds), CAB International, Wallingford, England 1993. p.195.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/37\" class=\"nounderline abstract_t\">Strickland GT. Gastrointestinal manifestations of schistosomiasis. Gut 1994; 35:1334.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/38\" class=\"nounderline abstract_t\">Bartley PB, Ramm GA, Jones MK, et al. A contributory role for activated hepatic stellate cells in the dynamics of Schistosoma japonicum egg-induced fibrosis. Int J Parasitol 2006; 36:993.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/39\" class=\"nounderline abstract_t\">Cheever AW, Hoffmann KF, Wynn TA. Immunopathology of schistosomiasis mansoni in mice and men. Immunol Today 2000; 21:465.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/40\" class=\"nounderline abstract_t\">Magnussen P, Muchiri E, Mungai P, et al. A school-based approach to the control of urinary schistosomiasis and intestinal helminth infections in children in Matuga, Kenya: impact of a two-year chemotherapy programme on prevalence and intensity of infections. Trop Med Int Health 1997; 2:825.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/41\" class=\"nounderline abstract_t\">Silva IM, Thiengo R, Concei&ccedil;&atilde;o MJ, et al. Cystoscopy in the diagnosis and follow-up of urinary schistosomiasis in Brazilian soldiers returning from Mozambique, Africa. Rev Inst Med Trop Sao Paulo 2006; 48:39.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/42\" class=\"nounderline abstract_t\">Brinkmann UK, Werler C, Traor&eacute; M, et al. Experiences with mass chemotherapy in the control of schistosomiasis in Mali. Trop Med Parasitol 1988; 39:167.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/43\" class=\"nounderline abstract_t\">King CH, Muchiri E, Ouma JH, Koech D. Chemotherapy-based control of schistosomiasis haematobia. IV. Impact of repeated annual chemotherapy on prevalence and intensity of Schistosoma haematobium infection in an endemic area of Kenya. Am J Trop Med Hyg 1991; 45:498.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/44\" class=\"nounderline abstract_t\">Richter J. The impact of chemotherapy on morbidity due to schistosomiasis. Acta Trop 2003; 86:161.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/45\" class=\"nounderline abstract_t\">Stelma FF, Talla I, Verle P, et al. Morbidity due to heavy Schistosoma mansoni infections in a recently established focus in northern Senegal. Am J Trop Med Hyg 1994; 50:575.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/46\" class=\"nounderline abstract_t\">Visser LG, Polderman AM, Stuiver PC. Outbreak of schistosomiasis among travelers returning from Mali, West Africa. Clin Infect Dis 1995; 20:280.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/47\" class=\"nounderline abstract_t\">Bour&eacute;e P, Caumes E. [Cercarial dermatitis]. Presse Med 2004; 33:490.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/48\" class=\"nounderline abstract_t\">Ross AG, Vickers D, Olds GR, et al. Katayama syndrome. Lancet Infect Dis 2007; 7:218.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/49\" class=\"nounderline abstract_t\">Bottieau E, Clerinx J, de Vega MR, et al. Imported Katayama fever: clinical and biological features at presentation and during treatment. J Infect 2006; 52:339.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/50\" class=\"nounderline abstract_t\">Loutan L, Farinelli T, Robert CF. [Acute schistosomiasis or Katayama syndrome: apropos of 2 mini-epidemics]. Schweiz Med Wochenschr 1996; 126:1482.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/51\" class=\"nounderline abstract_t\">Clerinx J, Van Gompel A. Schistosomiasis in travellers and migrants. Travel Med Infect Dis 2011; 9:6.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/52\" class=\"nounderline abstract_t\">Lambertucci JR. Acute schistosomiasis: clinical, diagnostic and therapeutic features. Rev Inst Med Trop Sao Paulo 1993; 35:399.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/53\" class=\"nounderline abstract_t\">Leshem E, Maor Y, Meltzer E, et al. Acute schistosomiasis outbreak: clinical features and economic impact. Clin Infect Dis 2008; 47:1499.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/54\" class=\"nounderline abstract_t\">Rocha MO, Greco DB, Pedroso ER, et al. Secondary cutaneous manifestations of acute schistosomiasis mansoni. Ann Trop Med Parasitol 1995; 89:425.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/55\" class=\"nounderline abstract_t\">Rocha MO, Pedroso ER, Lambertucci JR, et al. Gastro-intestinal manifestations of the initial phase of schistosomiasis mansoni. Ann Trop Med Parasitol 1995; 89:271.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/56\" class=\"nounderline abstract_t\">Rocha MO, Rocha RL, Pedroso ER, et al. Pulmonary manifestations in the initial phase of schistosomiasis mansoni. Rev Inst Med Trop Sao Paulo 1995; 37:311.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/57\" class=\"nounderline abstract_t\">Clerinx J, Bottieau E, Wichmann D, et al. Acute schistosomiasis in a cluster of travelers from Rwanda: diagnostic contribution of schistosome DNA detection in serum compared to parasitology and serology. J Travel Med 2011; 18:367.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/58\" class=\"nounderline abstract_t\">Jaur&eacute;guiberry S, Ansart S, Perez L, et al. Acute neuroschistosomiasis: two cases associated with cerebral vasculitis. Am J Trop Med Hyg 2007; 76:964.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/59\" class=\"nounderline abstract_t\">Lambertucci JR. Acute schistosomiasis mansoni: revisited and reconsidered. Mem Inst Oswaldo Cruz 2010; 105:422.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/60\" class=\"nounderline abstract_t\">Puylaert CA, van Thiel PP. IMAGES IN CLINICAL MEDICINE. Katayama Fever. N Engl J Med 2016; 374:469.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/61\" class=\"nounderline abstract_t\">Blanchard TJ. Schistosomiasis. Travel Med Infect Dis 2004; 2:5.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/62\" class=\"nounderline abstract_t\">Whitty CJ, Mabey DC, Armstrong M, et al. Presentation and outcome of 1107 cases of schistosomiasis from Africa diagnosed in a non-endemic country. Trans R Soc Trop Med Hyg 2000; 94:531.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/63\" class=\"nounderline abstract_t\">Lucey DR, Maguire JH. Schistosomiasis. Infect Dis Clin North Am 1993; 7:635.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/64\" class=\"nounderline abstract_t\">Gurarie D, Wang X, Bustinduy AL, King CH. Modeling the effect of chronic schistosomiasis on childhood development and the potential for catch-up growth with different drug treatment strategies promoted for control of endemic schistosomiasis. Am J Trop Med Hyg 2011; 84:773.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/65\" class=\"nounderline abstract_t\">King CH, Magak P, Salam EA, et al. Measuring morbidity in schistosomiasis mansoni: relationship between image pattern, portal vein diameter and portal branch thickness in large-scale surveys using new WHO coding guidelines for ultrasound in schistosomiasis. Trop Med Int Health 2003; 8:109.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/66\" class=\"nounderline abstract_t\">Gryseels B. The epidemiology of schistosomiasis in Burundi and its consequences for control. Trans R Soc Trop Med Hyg 1991; 85:626.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/67\" class=\"nounderline abstract_t\">Stephenson L. The impact of schistosomiasis on human nutrition. Parasitology 1993; 107 Suppl:S107.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/68\" class=\"nounderline abstract_t\">Stothard JR, Sousa-Figueiredo JC, Betson M, et al. Schistosomiasis in African infants and preschool children: let them now be treated! Trends Parasitol 2013; 29:197.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/69\" class=\"nounderline abstract_t\">A 57-Year-Old Woman With a Cecal Mass. Clin Infect Dis 2016; 63:656.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/70\" class=\"nounderline abstract_t\">Mu A, Fernandes I, Phillips D. A 57-Year-Old Woman With a Cecal Mass. Clin Infect Dis 2016; 63:703.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/71\" class=\"nounderline abstract_t\">Gabbi C, Bertolotti M, Iori R, et al. Acute abdomen associated with schistosomiasis of the appendix. Dig Dis Sci 2006; 51:215.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/72\" class=\"nounderline abstract_t\">Lamyman MJ, Noble DJ, Narang S, Dehalvi N. Small bowel obstruction secondary to intestinal schistosomiasis. Trans R Soc Trop Med Hyg 2006; 100:885.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/73\" class=\"nounderline abstract_t\">Gryseels B. Morbidity due to infection with Schistosoma mansoni: an update. Trop Geogr Med 1992; 44:189.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/74\" class=\"nounderline abstract_t\">Homeida M, Abdel-Gadir AF, Cheever AW, et al. Diagnosis of pathologically confirmed Symmers' periportal fibrosis by ultrasonography: a prospective blinded study. Am J Trop Med Hyg 1988; 38:86.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/75\" class=\"nounderline abstract_t\">Homeida MA, el Tom I, Nash T, Bennett JL. Association of the therapeutic activity of praziquantel with the reversal of Symmers' fibrosis induced by Schistosoma mansoni. Am J Trop Med Hyg 1991; 45:360.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/76\" class=\"nounderline abstract_t\">Dessein A, Arnaud V, He H, et al. Genetic analysis of human predisposition to hepatosplenic disease caused by schistosomes reveals the crucial role of connective tissue growth factor in rapid progression to severe hepatic fibrosis. Pathol Biol (Paris) 2013; 61:3.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/77\" class=\"nounderline abstract_t\">Dessein AJ, Hillaire D, Elwali NE, et al. Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet 1999; 65:709.</a></li><li class=\"breakAll\">Richter J, Hatz C, Campagne G, Bergquist R, Jenkins JM (Eds). Ultrasound in schistosomiasis. A Practical Guide to the Standardized Use of Ultrasonography for the Assessment of Schistosomiasis-related Morbidity. World Health Organization, Geneva 2000.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/79\" class=\"nounderline abstract_t\">Abdel-Wahab MF, Esmat G, Farrag A, et al. Grading of hepatic schistosomiasis by the use of ultrasonography. Am J Trop Med Hyg 1992; 46:403.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/80\" class=\"nounderline abstract_t\">Yazdanpanah Y, Thomas AK, Kardorff R, et al. Organometric investigations of the spleen and liver by ultrasound in Schistosoma mansoni endemic and nonendemic villages in Senegal. Am J Trop Med Hyg 1997; 57:245.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/81\" class=\"nounderline abstract_t\">Bezerra AS, D'Ippolito G, Caldana RP, et al. Chronic hepatosplenic schistosomiasis mansoni: magnetic resonance imaging and magnetic resonance angiography findings. Acta Radiol 2007; 48:125.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/82\" class=\"nounderline abstract_t\">Sarwat AK, Tag el Din MA, Bassiouni M, Ashmawi SS. Schistosomiasis of the lung. J Egypt Soc Parasitol 1986; 16:359.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/83\" class=\"nounderline abstract_t\">Andrade ZA, Andrade SG. Pathogenesis of schistosomal pulmonary arteritis. Am J Trop Med Hyg 1970; 19:305.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/84\" class=\"nounderline abstract_t\">FARID Z, GREER JW, ISHAK KG, et al. Chronic pulmonary schistosomiasis. Am Rev Tuberc 1959; 79:119.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/85\" class=\"nounderline abstract_t\">Lapa M, Dias B, Jardim C, et al. Cardiopulmonary manifestations of hepatosplenic schistosomiasis. Circulation 2009; 119:1518.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/86\" class=\"nounderline abstract_t\">Pedroso ER, Lambertucci JR, Greco DB, et al. Pulmonary schistosomiasis mansoni: post-treatment pulmonary clinical-radiological alterations in patients in the chronic phase: a double-blind study. Trans R Soc Trop Med Hyg 1987; 81:778.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/87\" class=\"nounderline abstract_t\">Ottesen EA, Weller PF. Eosinophilia following treatment of patients with schistosomiasis mansoni and Bancroft's filariasis. J Infect Dis 1979; 139:343.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/88\" class=\"nounderline abstract_t\">Corachan M, Valls ME, Gascon J, et al. Hematospermia: a new etiology of clinical interest. Am J Trop Med Hyg 1994; 50:580.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/89\" class=\"nounderline abstract_t\">Crump JA, Murdoch DR, Chambers ST, et al. Female genital schistosomiasis. J Travel Med 2000; 7:30.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/90\" class=\"nounderline abstract_t\">Feldmeier H, Daccal RC, Martins MJ, et al. Genital manifestations of schistosomiasis mansoni in women: important but neglected. Mem Inst Oswaldo Cruz 1998; 93 Suppl 1:127.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/91\" class=\"nounderline abstract_t\">Randrianasolo BS, Jourdan PM, Ravoniarimbinina P, et al. Gynecological manifestations, histopathological findings, and schistosoma-specific polymerase chain reaction results among women with Schistosoma haematobium infection: a cross-sectional study in Madagascar. J Infect Dis 2015; 212:275.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/92\" class=\"nounderline abstract_t\">Devidas A, Lamothe F, Develoux M, et al. [Morbidity due to bilharziasis caused by S. haematobium. Relationship between the bladder lesions observed by ultrasonography and the cystoscopic and anatomo-pathologic lesions]. Acta Trop 1988; 45:277.</a></li><li class=\"breakAll\">Farid Z. Schistosomes with Terminal-spined Eggs: Pathological and Clinical aspects. In: Human Schistosomiasis, Jordan P, Webbe G, Sturrock FS (Eds), CAB International, Wallingford, England 1993.</li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/94\" class=\"nounderline abstract_t\">Feldmeier H, Leutscher P, Poggensee G, Harms G. Male genital schistosomiasis and haemospermia. Trop Med Int Health 1999; 4:791.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/95\" class=\"nounderline abstract_t\">Smith JH, Christie JD. The pathobiology of Schistosoma haematobium infection in humans. Hum Pathol 1986; 17:333.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/96\" class=\"nounderline abstract_t\">Medhat A, Zarzour A, Nafeh M, et al. Evaluation of an ultrasonographic score for urinary bladder morbidity in Schistosoma haematobium infection. Am J Trop Med Hyg 1997; 57:16.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/97\" class=\"nounderline abstract_t\">King CH, Muchiri EM, Ouma JH. Age-targeted chemotherapy for control of urinary schistosomiasis in endemic populations. Mem Inst Oswaldo Cruz 1992; 87 Suppl 4:203.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/98\" class=\"nounderline abstract_t\">King CH. Ultrasound monitoring of structural urinary tract disease in Schistosoma haematobium infection. Mem Inst Oswaldo Cruz 2002; 97 Suppl 1:149.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/99\" class=\"nounderline abstract_t\">Koukounari A, Gabrielli AF, Toure S, et al. Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso. J Infect Dis 2007; 196:659.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/100\" class=\"nounderline abstract_t\">Richter J, Poggensee G, Kjetland EF, et al. Reversibility of lower reproductive tract abnormalities in women with Schistosoma haematobium infection after treatment with praziquantel--an interim report. Acta Trop 1996; 62:289.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/101\" class=\"nounderline abstract_t\">Burki A, Tanner M, Burnier E, et al. Comparison of ultrasonography, intravenous pyelography and cystoscopy in detection of urinary tract lesions due to Schistosoma haematobium. Acta Trop 1986; 43:139.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/102\" class=\"nounderline abstract_t\">Dittrich M, Doehring E. Ultrasonographical aspects of urinary schistosomiasis: assessment of morphological lesions in the upper and lower urinary tract. Pediatr Radiol 1986; 16:225.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/103\" class=\"nounderline abstract_t\">Bedwani R, Renganathan E, El Kwhsky F, et al. Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 1998; 77:1186.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/104\" class=\"nounderline abstract_t\">Kjetland EF, Mduluza T, Ndhlovu PD, et al. Genital schistosomiasis in women: a clinical 12-month in vivo study following treatment with praziquantel. Trans R Soc Trop Med Hyg 2006; 100:740.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/105\" class=\"nounderline abstract_t\">Chen W, Flynn EA, Shreefter MJ, Blagg NA. Schistosomiasis: an unusual finding of the cervix. Obstet Gynecol 2012; 119:472.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/106\" class=\"nounderline abstract_t\">Kjetland EF, Ndhlovu PD, Gomo E, et al. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS 2006; 20:593.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/107\" class=\"nounderline abstract_t\">Mbabazi PS, Andan O, Fitzgerald DW, et al. Examining the relationship between urogenital schistosomiasis and HIV infection. PLoS Negl Trop Dis 2011; 5:e1396.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/108\" class=\"nounderline abstract_t\">Secor WE. The effects of schistosomiasis on HIV/AIDS infection, progression and transmission. Curr Opin HIV AIDS 2012; 7:254.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/109\" class=\"nounderline abstract_t\">Szekeres C, Galletout P, Jaureguiberry S, et al. Neurological presentation of schistosomiasis. Lancet 2013; 381:1788.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/110\" class=\"nounderline abstract_t\">Ferrari TC, Moreira PR, Cunha AS. Clinical characterization of neuroschistosomiasis due to Schistosoma mansoni and its treatment. Acta Trop 2008; 108:89.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/111\" class=\"nounderline abstract_t\">Nascimento-Carvalho CM, Moreno-Carvalho OA. Neuroschistosomiasis due to Schistosoma mansoni: a review of pathogenesis, clinical syndromes and diagnostic approaches. Rev Inst Med Trop Sao Paulo 2005; 47:179.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/112\" class=\"nounderline abstract_t\">Silva LC, Maciel PE, Ribas JG, et al. Treatment of schistosomal myeloradiculopathy with praziquantel and corticosteroids and evaluation by magnetic resonance imaging: a longitudinal study. Clin Infect Dis 2004; 39:1618.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/113\" class=\"nounderline abstract_t\">Lambertucci JR, Sousa-Pereira SR, Silva LC. [Myeloradiculopathy in acute schistosomiasis mansoni]. Rev Soc Bras Med Trop 2005; 38:277.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/114\" class=\"nounderline abstract_t\">Ferrari TC, Moreira PR. Neuroschistosomiasis: clinical symptoms and pathogenesis. Lancet Neurol 2011; 10:853.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/115\" class=\"nounderline abstract_t\">Ross AG, McManus DP, Farrar J, et al. Neuroschistosomiasis. J Neurol 2012; 259:22.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/116\" class=\"nounderline abstract_t\">Scrimgeour EM, Gajdusek DC. Involvement of the central nervous system in Schistosoma mansoni and S. haematobium infection. A review. Brain 1985; 108 ( Pt 4):1023.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/117\" class=\"nounderline abstract_t\">Naus CW, Chipwete J, Visser LG, et al. The contribution made by Schistosoma infection to non-traumatic disorders of the spinal cord in Malawi. Ann Trop Med Parasitol 2003; 97:711.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/118\" class=\"nounderline abstract_t\">Carod Artal FJ, Vargas AP, Horan TA, et al. Schistosoma mansoni myelopathy: clinical and pathologic findings. Neurology 2004; 63:388.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/119\" class=\"nounderline abstract_t\">Ferrari TC. Spinal cord schistosomiasis. A report of 2 cases and review emphasizing clinical aspects. Medicine (Baltimore) 1999; 78:176.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/120\" class=\"nounderline abstract_t\">Carod-Artal FJ. Neurological complications of Schistosoma infection. Trans R Soc Trop Med Hyg 2008; 102:107.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/121\" class=\"nounderline abstract_t\">Pittella JE, Lana-Peixoto MA. Brain involvement in hepatosplenic Schistosomiasis mansoni. Brain 1981; 104:621.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/122\" class=\"nounderline abstract_t\">Camuset G, Wolff V, Marescaux C, et al. Cerebral vasculitis associated with Schistosoma mansoni infection. BMC Infect Dis 2012; 12:220.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/123\" class=\"nounderline abstract_t\">Bierman WF, Wetsteyn JC, van Gool T. Presentation and diagnosis of imported schistosomiasis: relevance of eosinophilia, microscopy for ova, and serology. J Travel Med 2005; 12:9.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/124\" class=\"nounderline abstract_t\">Checkley AM, Chiodini PL, Dockrell DH, et al. Eosinophilia in returning travellers and migrants from the tropics: UK recommendations for investigation and initial management. J Infect 2010; 60:1.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/125\" class=\"nounderline abstract_t\">Pardo J, Carranza C, Muro A, et al. Helminth-related Eosinophilia in African immigrants, Gran Canaria. Emerg Infect Dis 2006; 12:1587.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/126\" class=\"nounderline abstract_t\">Rocha MO, Pedroso ER, Greco DB, et al. Pathogenetic factors of acute schistosomiasis mansoni: correlation of worm burden, IgE, blood eosinophilia and intensity of clinical manifestations. Trop Med Int Health 1996; 1:213.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/127\" class=\"nounderline abstract_t\">Mahmoud AA. The ecology of eosinophils in schistosomiasis. J Infect Dis 1982; 145:613.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/128\" class=\"nounderline abstract_t\">Bustinduy AL, Sousa-Figueiredo JC, Adriko M, et al. Fecal occult blood and fecal calprotectin as point-of-care markers of intestinal morbidity in Ugandan children with Schistosoma mansoni infection. PLoS Negl Trop Dis 2013; 7:e2542.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/129\" class=\"nounderline abstract_t\">Harries AD, Fryatt R, Walker J, et al. Schistosomiasis in expatriates returning to Britain from the tropics: a controlled study. Lancet 1986; 1:86.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/130\" class=\"nounderline abstract_t\">Sarda RK, Minjas JN, Mahikwano LF. Evaluation of indirect screening techniques for the detection of Schistosoma haematobium infection in an urban area, Dar es Salaam, Tanzania. Acta Trop 1985; 42:241.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/131\" class=\"nounderline abstract_t\">Stephenson LS, Latham MC, Kinoti SN, Oduori ML. Sensitivity and specificity of reagent strips in screening of Kenyan children for Schistosoma haematobium infection. Am J Trop Med Hyg 1984; 33:862.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/132\" class=\"nounderline abstract_t\">Taylor P, Chandiwana SK, Matanhire D. Evaluation of the reagent strip test for haematuria in the control of Schistosoma haematobium infection in schoolchildren. Acta Trop 1990; 47:91.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/133\" class=\"nounderline abstract_t\">King CH, Bertsch D. Meta-analysis of urine heme dipstick diagnosis of Schistosoma haematobium infection, including low-prevalence and previously-treated populations. PLoS Negl Trop Dis 2013; 7:e2431.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/134\" class=\"nounderline abstract_t\">Rocha H, Kirk JW, Hearey CD Jr. Prolonged Salmonella bacteremia in patients with Schistosoma mansoni infection. Arch Intern Med 1971; 128:254.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/135\" class=\"nounderline abstract_t\">Brown M, Kizza M, Watera C, et al. Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. J Infect Dis 2004; 190:1869.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/136\" class=\"nounderline abstract_t\">Downs JA, de Dood CJ, Dee HE, et al. Schistosomiasis and Human Immunodeficiency Virus in Men in Tanzania. Am J Trop Med Hyg 2017.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/137\" class=\"nounderline abstract_t\">Leutscher PD, Pedersen M, Raharisolo C, et al. Increased prevalence of leukocytes and elevated cytokine levels in semen from Schistosoma haematobium-infected individuals. J Infect Dis 2005; 191:1639.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/138\" class=\"nounderline abstract_t\">Feldmeier H, Krantz I, Poggensee G. Female genital schistosomiasis as a risk-factor for the transmission of HIV. Int J STD AIDS 1994; 5:368.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/139\" class=\"nounderline abstract_t\">Poggensee G, Feldmeier H. Female genital schistosomiasis: facts and hypotheses. Acta Trop 2001; 79:193.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/140\" class=\"nounderline abstract_t\">Vennervald BJ, Dunne DW. Morbidity in schistosomiasis: an update. Curr Opin Infect Dis 2004; 17:439.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/141\" class=\"nounderline abstract_t\">Kallestrup P, Zinyama R, Gomo E, et al. Schistosomiasis and HIV-1 infection in rural Zimbabwe: effect of treatment of schistosomiasis on CD4 cell count and plasma HIV-1 RNA load. J Infect Dis 2005; 192:1956.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/142\" class=\"nounderline abstract_t\">Ganley-Leal LM, Mwinzi PN, Cetre-Sossah CB, et al. Correlation between eosinophils and protection against reinfection with Schistosoma mansoni and the effect of human immunodeficiency virus type 1 coinfection in humans. Infect Immun 2006; 74:2169.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/143\" class=\"nounderline abstract_t\">Joseph S, Jones FM, Laidlaw ME, et al. Impairment of the Schistosoma mansoni-specific immune responses elicited by treatment with praziquantel in Ugandans with HIV-1 coinfection. J Infect Dis 2004; 190:613.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/144\" class=\"nounderline abstract_t\">de Silva S, Walsh J, Brown M. Symptomatic Schistosoma mansoni infection as an immune restoration phenomenon in a patient receiving antiretroviral therapy. Clin Infect Dis 2006; 42:303.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/145\" class=\"nounderline abstract_t\">Lambertucci JR, Rayes AA, Serufo JC, et al. Schistosomiasis and associated infections. Mem Inst Oswaldo Cruz 1998; 93 Suppl 1:135.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/146\" class=\"nounderline abstract_t\">Farid A, Al-Sherbiny M, Osman A, et al. Schistosoma infection inhibits cellular immune responses to core HCV peptides. Parasite Immunol 2005; 27:189.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/147\" class=\"nounderline abstract_t\">Abdel-Rahman M, El-Sayed M, El Raziky M, et al. Coinfection with hepatitis C virus and schistosomiasis: fibrosis and treatment response. World J Gastroenterol 2013; 19:2691.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/148\" class=\"nounderline abstract_t\">Kamal SM, Turner B, He Q, et al. Progression of fibrosis in hepatitis C with and without schistosomiasis: correlation with serum markers of fibrosis. Hepatology 2006; 43:771.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/149\" class=\"nounderline abstract_t\">Pierrot C, Wilson S, Lallet H, et al. Identification of a novel antigen of Schistosoma mansoni shared with Plasmodium falciparum and evaluation of different cross-reactive antibody subclasses induced by human schistosomiasis and malaria. Infect Immun 2006; 74:3347.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/150\" class=\"nounderline abstract_t\">Yosry A. Schistosomiasis and neoplasia. Contrib Microbiol 2006; 13:81.</a></li><li><a href=\"https://www.uptodate.com/contents/epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis/abstract/151\" class=\"nounderline abstract_t\">Lyke KE, Dicko A, Dabo A, et al. Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. Am J Trop Med Hyg 2005; 73:1124.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5717 Version 19.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H6283927\"><span>SUMMARY</span></a></li><li><a href=\"#H6283708\" id=\"outline-link-H6283708\">INTRODUCTION</a></li><li><a href=\"#H6283714\" id=\"outline-link-H6283714\">MICROBIOLOGY</a></li><li><a href=\"#H6283720\" id=\"outline-link-H6283720\">EPIDEMIOLOGY</a><ul><li><a href=\"#H6283726\" id=\"outline-link-H6283726\">Life cycle</a></li></ul></li><li><a href=\"#H6283902\" id=\"outline-link-H6283902\">PATHOGENESIS</a></li><li><a href=\"#H6283780\" id=\"outline-link-H6283780\">CLINICAL MANIFESTATIONS</a><ul><li><a href=\"#H6283786\" id=\"outline-link-H6283786\">Acute infection</a><ul><li><a href=\"#H6283793\" id=\"outline-link-H6283793\">- Swimmer's itch</a></li><li><a href=\"#H6283799\" id=\"outline-link-H6283799\">- Acute schistosomiasis syndrome</a></li></ul></li><li><a href=\"#H6283805\" id=\"outline-link-H6283805\">Chronic infection</a><ul><li><a href=\"#H6283811\" id=\"outline-link-H6283811\">- Intestinal schistosomiasis</a></li><li><a href=\"#H6283817\" id=\"outline-link-H6283817\">- Hepatosplenic schistosomiasis</a><ul><li><a href=\"#H3348962\" id=\"outline-link-H3348962\">Pulmonary complications</a></li></ul></li><li><a href=\"#H7411545\" id=\"outline-link-H7411545\">- Genitourinary schistosomiasis</a></li><li><a href=\"#H3328511\" id=\"outline-link-H3328511\">- Glomerular disease</a></li></ul></li><li><a href=\"#H3347989\" id=\"outline-link-H3347989\">Neuroschistosomiasis</a></li></ul></li><li><a href=\"#H14470957\" id=\"outline-link-H14470957\">LABORATORY FINDINGS</a></li><li><a href=\"#H6283853\" id=\"outline-link-H6283853\">ASSOCIATED INFECTIONS</a><ul><li><a href=\"#H6283859\" id=\"outline-link-H6283859\">Bacteremia and bacteriuria</a></li><li><a href=\"#H6283865\" id=\"outline-link-H6283865\">HIV infection</a></li><li><a href=\"#H6283871\" id=\"outline-link-H6283871\">Viral hepatitis</a></li><li><a href=\"#H6283883\" id=\"outline-link-H6283883\">Malaria</a></li></ul></li><li><a href=\"#H6283927\" id=\"outline-link-H6283927\">SUMMARY</a></li><li><a href=\"#H6290124\" id=\"outline-link-H6290124\">ACKNOWLEDGMENTS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"ID/5717|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=ID/96779\" class=\"graphic graphic_diagnosticimage\">- Urinary schistosomiasis</a></li><li><a href=\"image.htm?imageKey=ID/96780\" class=\"graphic graphic_diagnosticimage\">- Spinal schistosomiasis</a></li><li><a href=\"image.htm?imageKey=ID/96781\" class=\"graphic graphic_diagnosticimage\">- Cerebral schistosomiasis</a></li></ul></li><li><div id=\"ID/5717|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/90007\" class=\"graphic graphic_figure\">- Schistosomiasis life cycle</a></li></ul></li><li><div id=\"ID/5717|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/94653\" class=\"graphic graphic_picture\">- Schisto mucosal polyps</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-schistosomiasis\" class=\"medical medical_review\">Diagnosis of schistosomiasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-and-risk-factors-of-urothelial-transitional-cell-carcinoma-of-the-bladder\" class=\"medical medical_review\">Epidemiology and risk factors of urothelial (transitional cell) carcinoma of the bladder</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=noncirrhotic-portal-hypertension\" class=\"medical medical_review\">Noncirrhotic portal hypertension</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=schistosomiasis-and-glomerular-disease\" class=\"medical medical_review\">Schistosomiasis and glomerular disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-and-prevention-of-schistosomiasis\" class=\"medical medical_review\">Treatment and prevention of schistosomiasis</a></li></ul></div></div>","javascript":null}